Radar | Aug 14,2021
The National Veterinary Institute is ready to begin production of animal pharmaceuticals at a plant in Bishoftu (Debre Zeit).
The institute has been upgrading the existing plant that manufactures vaccines with an investment of 100 million Br. The plant, which sits on 1,500Sqm of land, will start production in two months.
When it becomes fully operational, the institute will be able to satisfy 15pc of domestic demand and create jobs for 62 people. Animal antibiotic and anti-parasite drugs in 12 tablet types will be produced at the plant that has been under construction since 2016. The machinery was imported from India at a cost of 70 million Br, and Indian firm Fabtech Technologies International Limited installed the machines, while the institute carried out the civil work.
“We would be already producing if it wasn’t for power shortages,” said Awel Abduljebar, communications officer of the Institute. “We have been facing similar problems for the past two years.”
As a result of power shortages, the institute lost 10 million Br in fuel costs and five million Birr in expired vaccines, according to Matewos Mena, the institute's engineering & maintenance director.
Importers of animal drugs are hopeful that the institute’s investment will help their businesses.
“The construction of the plant will ease supply problems and save the lives of many animals,” said Hailu Meles (DVM), manager of GASCO Trading Plc, which imports animal drugs. “It will also reduce the contraband trade in drugs that were not previously in sufficient supply.”
Gasco is one of the 69 veterinary medicine and equipment importers in Ethiopia. There are as well 48 wholesalers and 219 retailers of animal drugs.
The institute, established almost a decade ago under the former Ministry of Agriculture with the technical assistance of the French Government, has the vaccine production capacity of close to 200 million doses a year. This has risen from four million doses a year in its earlier years.
Currently, the institute is producing 22 types of animal vaccines with a target of reaching an annual production capability of 365.34 million doses by 2020.
Dinka Ayana (DVM), dean of veterinary medicine & agriculture at Addis Abeba University, lauds the institute for the new investment it made.
"The new factory will save the country's foreign currency reserves and make animal drugs in the market cheaper," he said. “It will also reduce the contraband trade in animal drugs, many of which have no expiry dates and are not stored properly when being transported.”
PUBLISHED ON
Jan 12,2019 [ VOL
19 , NO
976]
Fortune News | May 29,2021
View From Arada | Dec 25,2021
Films Review | Nov 16,2019
Radar | Oct 23,2021
Commentaries | May 21,2022
Dec 24 , 2022
Biniam Mikru heads the department of cabinet affairs under Mayor Adanech Abiebie. But...
Jul 2 , 2022 . By RUTH TAYE
On a rainy afternoon last week, a coffee processing facility in the capital's Akaki-Qality District was abuzz with activ...
Nov 27 , 2021
Against my will, I have witnessed the most terrible defeat of reason and the most sa...
Nov 13 , 2021
Plans and reality do not always gel. They rarely do in a fast-moving world. Every act...
Sep 16 , 2023
The Ethiopian economic narrative oscillates between pockets of resilience and signifi...
Sep 10 , 2023
Earlier this Ethiopian fiscal year, the heralding of a peace deal became synonymous w...
Sep 2 , 2023
An unfolding horror story revealed the human cost of desperate migration in the arid...
Aug 26 , 2023
In the rain-drenched streets of Addis Abeba, there was a distinct ripple of optimism...
Loading your updates...